Status:
UNKNOWN
OCTA Analysis of Macular and Papillary Perfusion After Refractive Surgery in Myopes
Lead Sponsor:
Tanta University
Conditions:
Myopia
Perfusion; Complications
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Refractive surgery for correction of myopia is very common nowadays. However, various refractive techniques may be associated with increase in the IOP, especially during flap creation. It is assumed t...
Detailed Description
Myopia is the most prevalent ocular disorder in children worldwide, and one of the major causes of visual deterioration in all age groups. Highest prevalence rates are in East Asian countries (affecti...
Eligibility Criteria
Inclusion
- Age: between 20 - 35 years
- Patients: who are seeking and fit for refractive surgery
- Spherical equivalent refractive error: between (-2 to -9 D)
Exclusion
- Maculopathies (hereditary or acquired)
- optic nerve head pathologies (tilted disc, drusen, optic disc edema, atrophy, etc.)
- optic neuropathies (demyelinating, infectious, ischemic, etc.)
- adjusted IOP for central corneal thickness more than 21 mmHg
- surgery-induced corneal edema
- dense cataracts that can disrupt images
- systemic diseases (vasculitis, diabetes mellitus, hypertension, etc.)
- any previous ocular surgery,
- patients with bad quality images or complicated surgeries will be excluded
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04424069
Start Date
March 1 2020
End Date
December 1 2020
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology Department, Faculty of medicine, Tanta Univeristy
Tanta, Egypt, 31515